This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Check our privacy policy here.
GalChimia receives the INNOVATIVE SME distinction
May 21, 2021The INNOVATIVE SME distinction recognizes GalChimia’s commitment to innovation and the effort to develop R&D projects.
Read More
GalChimia, patrocinador de los XX Premios SEQT
May 13, 2021En GalChimia celebramos nuestra relación con la SEQT, premiando la Pasión por la Química de investigadores noveles en el campo de la química médica.
Read More
Resultados del proyecto IO4COLON
April 14, 2021Presentamos los resultados del proyecto IO4COLON, nuestra plataforma colaborativa con AMSlab y Oncostellae para el desarrollo de nuevos fármacos inmunoterapéuticos para el tratamiento de cáncer de colon.
Read More
GalChimia in CSBJ: Novel thermophilic esterase with unique catalytic activity
March 4, 2021A few years back, we participated in the research project HOTDROPS, whose goal was to search for new biocatalysts through the development of an ultrahigh-throughput platform. The project thus combined three sciences: enzymology, microfluid technology, and organic chemistry.
Read More
2020 in Numbers
February 17, 2021One more year of great productivity for GalChimia! Click here to see the achievements of our teams of chemists.
Read More
Synthesis of Pyrazoles from Acetophenones in Flow
February 2, 2021Check out our latest Technical Note where we describe a continuous process developed in house for the efficient synthesis of substituted pyrazoles.
Read MoreArtículo de prueba
January 19, 2021Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim…
Read More
GalChimia in J. Med. Chem. – A New Clinical Candidate for Pain Management
December 1, 2020Our latest article with Esteve Pharmaceuticals is now available in J. Med. Chem., with participation as well of researchers from UPF and UGR. Click here to read it!
Read More
GalChimia in RSC Med. Chem. – Drug Discovery for the Treatment of Visceral Leishmaniasis
August 20, 2020Check out our new paper about the identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis
Read More